Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: EntreMed (ENMD)

No earlier versions found for this Subject.

Return to EntreMed (ENMD)

Hello All,

I would like to initate discussion on this biotech company. I read a highly favorable article on ENMD in the most recent issue of Fortune magazine. They have the rights to Harvard scientist J. Folkman's research on the angiostatin molecule, and he has recently shown some promising results regarding the inhibition of cancer metastasis. The stock has done well recently and I think it's only going to do better. Any opinions?